Clinical trial
Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy
NCT00085761 · NeurogesX, Industry · Terminated
Key facts
| NCT number | NCT00085761 |
|---|---|
| Title | Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy |
| Official title | An International, Multicenter, Randomized, Double-Blind, 12-Week Controlled Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy |
| Lead sponsor | NeurogesX, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Peripheral Nervous System Diseases, Pain |
| Intervention type | Drug |
| Interventions | Capsaicin Dermal Patch |
| First posted | Jun 17, 2004 |
| Last update posted | Mar 6, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: